Therapies
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator
12 days ago | By Xconomy
IFM Therapeutics has raised $55.5 million to launch its third drug subsidiary as well as an incubator, both of which are focused on developing new therapies for inflammatory diseases and cancers. Those endeavors will be led by a familiar face. Boston-based IFM has promoted its vice president of research and development, Martin Seidel, to become its CEO and a member of the board of directors. Gary Glick, IFM's co-founder and CEO since its formation two years ago , is taking on a new role as executive chairman of the board. IFM Therapeutics operates a business structure that houses its...
Read more ...
Search by Tags
Therapies Drugs Discovery Cancer Therapeutics Drug Research Boston Boston blog main Boston top stories National blog main National top stories New York blog main New York top stories Abingworth Atlas Venture Autoimmune Diseases Biotech Cancer Deals Gary Glick IFM Therapeutics Inflammatory Diseases Investing Life Sciences Martin Seidel Novartis Omega Funds Startups Venture CapitalWorld Biotechnology Congress 2019
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
World Biotechnology Congress 2019
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
2nd International Conference on Tissue Science and Regenerative Medicine
This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...
Subsequent Use of a Pressure Sensor to Record Intra-abdominal Pressure after...
Stefan Niederauer , Brian Cottle , Xiaoming Sheng , James Ashton-Miller , John DeLancey , Robert Hitchcock Early Access Note: Early Access articles are new content made... Read more ...
Bio Roundup: Sarepta's Approval, Merck M&A, Drug Price Bill & More
If you're keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there's Sarepta... Read more ...
An Automated Framework for Large scale Retrospective Analysis of Ultrasound...
Pradeeba Sridar , Ashnil Kumar , Ann Quinton , Narelle June Kennedy , Ralph Nanan , Jinman Kim Early Access Note: Early Access articles are new content made available in... Read more ...
IAmScience Madison Green
By Mariah Cox | Bond LSC It's hard for a sixth-grader to nail down exactly what she wants to do for the rest of her life, but that's when the process started for Madison Green... Read more ...
Focusing on Research in Departmental Honors Program
The Department of Biological and Agricultural Engineering participates in the College of Engineering Honors Program, geared towards high achieving students looking for... Read more ...
Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
A prescription pill derived from fish-oil pill received the regulatory nod Friday to expand its use as a supplementary treatment, alongside statins, to more patients at risk of... Read more ...
Biotech Briefing: Illumina Spin-out Verogen Buys GEDmatch
Reports + Research Illumina Spin-out Verogen Buys GEDmatch GEDmatch, a genealogy website, was launched from obscurity for its role in helping catch the Golden State Killer-a... Read more ...
AveXis Inc.: Senior Manager, Data Integrity
AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...
Vireo: Bayesian demultiplexing of pooled single-cell RNA-seq data without...
Multiplexed single-cell RNA-seq analysis of multiple samples using pooling is a promising experimental design, offering increased throughput while allowing to overcome batch... Read more ...
Application of Raman Spectroscopy in Monoclonal Antibody Producing...
Abstract Monoclonal antibodies are biopharmaceuticals produced by mammalian cell lines in bioreactors at a variety of scales. Cell engineering, media optimization, process... Read more ...